APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Protein Production Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Protein Production Service Market Analysis and Forecast 2026-2032

16 April 2026221 pages

Choose your research edition.

Industry ResearchRecombinant Protein Production Service Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Protein Production Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Recombinant Protein Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Protein Production Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Recombinant Protein Production Service Market Analysis and Forecast 2026-2032221 pages · $4,950 USD

Market perspective

The global Recombinant Protein Production Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Recombinant Protein Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Protein Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Protein Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Protein Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Recombinant Protein Production Service include Charles River, Biomatik, R&D Systems, Applied Biological Materials Inc. (abm), VectorBuilder, BiologicsCorp, Proteos, RayBiotech and Leinco Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Recombinant Protein Production Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Protein Production Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Recombinant Protein Production Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Protein Production Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Protein Production Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Protein Production Service revenue, projected growth trends, production technology, application and end-user industry.

Recombinant Protein Production Service Segment by Company

Charles River

Biomatik

R&D Systems

Applied Biological Materials Inc. (abm)

VectorBuilder

BiologicsCorp

Proteos

RayBiotech

Leinco Technologies

Kinexus Bioinformatics

InVivo BioTech Services GmbH

Expression Systems

Creative Biolabs

G &P Biosciences

Eurofins Discovery

Levprot Bioscience

eEnzyme

NorthX Biologics

Jubilant Biosys

GenScript

Boster Bio

Sino Biological

WuXi Biologic

CUSABIO TECHNOLOGY

Recombinant Protein Production Service Segment by Type

Mammalian Cell Based

Bacteria Based

Insect Cell Based

Others

Recombinant Protein Production Service Segment by Application

Biomedicine

Industrial Biotechnology

Therapeutics

Others

Recombinant Protein Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Recombinant Protein Production Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Recombinant Protein Production Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Production Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Protein Production Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Mammalian Cell Based Major Player Table 3. Bacteria Based Major Player Table 4. Insect Cell Based Major Player Table 5. Others Major Player Table 6. Global Recombinant Protein Production Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Biomedicine Major Player Table 8. Industrial Biotechnology Major Player Table 9. Therapeutics Major Player Table 10. Others Major Player Table 11. Recombinant Protein Production Service Industry Trends Table 12. Recombinant Protein Production Service Industry Drivers Table 13. Recombinant Protein Production Service Industry Opportunities and Challenges Table 14. Recombinant Protein Production Service Industry Restraints Table 15. Global Recombinant Protein Production Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Recombinant Protein Production Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Recombinant Protein Production Service Market Share by Region (2021-2026) Table 18. Global Recombinant Protein Production Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Recombinant Protein Production Service Market Share by Region (2027-2032) Table 20. Global Recombinant Protein Production Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Recombinant Protein Production Service Revenue Market Share by Players (2021-2026) Table 22. Global Recombinant Protein Production Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Recombinant Protein Production Service Key Players Headquarters & Area Served Table 24. Global Recombinant Protein Production Service Players, Product Type & Application Table 25. Global Recombinant Protein Production Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Recombinant Protein Production Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Recombinant Protein Production Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Recombinant Protein Production Service Revenue Market Share by Type (2021-2026) Table 32. Global Recombinant Protein Production Service Revenue Market Share by Type (2027-2032) Table 33. Global Recombinant Protein Production Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Recombinant Protein Production Service Revenue Market Share by Application (2021-2026) Table 37. Global Recombinant Protein Production Service Revenue Market Share by Application (2027-2032) Table 38. Charles River Company Information Table 39. Charles River Business Overview Table 40. Charles River Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Charles River Recombinant Protein Production Service Product Portfolio Table 42. Charles River Recent Development Table 43. Biomatik Company Information Table 44. Biomatik Business Overview Table 45. Biomatik Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Biomatik Recombinant Protein Production Service Product Portfolio Table 47. Biomatik Recent Development Table 48. R&D Systems Company Information Table 49. R&D Systems Business Overview Table 50. R&D Systems Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. R&D Systems Recombinant Protein Production Service Product Portfolio Table 52. R&D Systems Recent Development Table 53. Applied Biological Materials Inc. (abm) Company Information Table 54. Applied Biological Materials Inc. (abm) Business Overview Table 55. Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Product Portfolio Table 57. Applied Biological Materials Inc. (abm) Recent Development Table 58. VectorBuilder Company Information Table 59. VectorBuilder Business Overview Table 60. VectorBuilder Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. VectorBuilder Recombinant Protein Production Service Product Portfolio Table 62. VectorBuilder Recent Development Table 63. BiologicsCorp Company Information Table 64. BiologicsCorp Business Overview Table 65. BiologicsCorp Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. BiologicsCorp Recombinant Protein Production Service Product Portfolio Table 67. BiologicsCorp Recent Development Table 68. Proteos Company Information Table 69. Proteos Business Overview Table 70. Proteos Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Proteos Recombinant Protein Production Service Product Portfolio Table 72. Proteos Recent Development Table 73. RayBiotech Company Information Table 74. RayBiotech Business Overview Table 75. RayBiotech Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. RayBiotech Recombinant Protein Production Service Product Portfolio Table 77. RayBiotech Recent Development Table 78. Leinco Technologies Company Information Table 79. Leinco Technologies Business Overview Table 80. Leinco Technologies Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Leinco Technologies Recombinant Protein Production Service Product Portfolio Table 82. Leinco Technologies Recent Development Table 83. Kinexus Bioinformatics Company Information Table 84. Kinexus Bioinformatics Business Overview Table 85. Kinexus Bioinformatics Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Kinexus Bioinformatics Recombinant Protein Production Service Product Portfolio Table 87. Kinexus Bioinformatics Recent Development Table 88. InVivo BioTech Services GmbH Company Information Table 89. InVivo BioTech Services GmbH Business Overview Table 90. InVivo BioTech Services GmbH Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. InVivo BioTech Services GmbH Recombinant Protein Production Service Product Portfolio Table 92. InVivo BioTech Services GmbH Recent Development Table 93. Expression Systems Company Information Table 94. Expression Systems Business Overview Table 95. Expression Systems Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Expression Systems Recombinant Protein Production Service Product Portfolio Table 97. Expression Systems Recent Development Table 98. Creative Biolabs Company Information Table 99. Creative Biolabs Business Overview Table 100. Creative Biolabs Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Creative Biolabs Recombinant Protein Production Service Product Portfolio Table 102. Creative Biolabs Recent Development Table 103. G &P Biosciences Company Information Table 104. G &P Biosciences Business Overview Table 105. G &P Biosciences Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. G &P Biosciences Recombinant Protein Production Service Product Portfolio Table 107. G &P Biosciences Recent Development Table 108. Eurofins Discovery Company Information Table 109. Eurofins Discovery Business Overview Table 110. Eurofins Discovery Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Eurofins Discovery Recombinant Protein Production Service Product Portfolio Table 112. Eurofins Discovery Recent Development Table 113. Levprot Bioscience Company Information Table 114. Levprot Bioscience Business Overview Table 115. Levprot Bioscience Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Levprot Bioscience Recombinant Protein Production Service Product Portfolio Table 117. Levprot Bioscience Recent Development Table 118. eEnzyme Company Information Table 119. eEnzyme Business Overview Table 120. eEnzyme Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. eEnzyme Recombinant Protein Production Service Product Portfolio Table 122. eEnzyme Recent Development Table 123. NorthX Biologics Company Information Table 124. NorthX Biologics Business Overview Table 125. NorthX Biologics Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. NorthX Biologics Recombinant Protein Production Service Product Portfolio Table 127. NorthX Biologics Recent Development Table 128. Jubilant Biosys Company Information Table 129. Jubilant Biosys Business Overview Table 130. Jubilant Biosys Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Jubilant Biosys Recombinant Protein Production Service Product Portfolio Table 132. Jubilant Biosys Recent Development Table 133. GenScript Company Information Table 134. GenScript Business Overview Table 135. GenScript Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. GenScript Recombinant Protein Production Service Product Portfolio Table 137. GenScript Recent Development Table 138. Boster Bio Company Information Table 139. Boster Bio Business Overview Table 140. Boster Bio Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Boster Bio Recombinant Protein Production Service Product Portfolio Table 142. Boster Bio Recent Development Table 143. Sino Biological Company Information Table 144. Sino Biological Business Overview Table 145. Sino Biological Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Sino Biological Recombinant Protein Production Service Product Portfolio Table 147. Sino Biological Recent Development Table 148. WuXi Biologic Company Information Table 149. WuXi Biologic Business Overview Table 150. WuXi Biologic Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. WuXi Biologic Recombinant Protein Production Service Product Portfolio Table 152. WuXi Biologic Recent Development Table 153. CUSABIO TECHNOLOGY Company Information Table 154. CUSABIO TECHNOLOGY Business Overview Table 155. CUSABIO TECHNOLOGY Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. CUSABIO TECHNOLOGY Recombinant Protein Production Service Product Portfolio Table 157. CUSABIO TECHNOLOGY Recent Development Table 158. North America Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 161. North America Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 162. North America Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Recombinant Protein Production Service Revenue by Country (2021-2026) & (US$ Million) Table 164. North America Recombinant Protein Production Service Revenue by Country (US$ Million) & (2027-2032) Table 165. Europe Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe Recombinant Protein Production Service Revenue by Country (2021-2026) & (US$ Million) Table 171. Europe Recombinant Protein Production Service Revenue by Country (US$ Million) & (2027-2032) Table 172. China Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 173. China Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 174. China Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 175. China Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Recombinant Protein Production Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Recombinant Protein Production Service Revenue by Region (US$ Million) & (2021-2026) Table 182. Asia Recombinant Protein Production Service Revenue by Region (US$ Million) & (2027-2032) Table 183. SAMEA Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Recombinant Protein Production Service Revenue by Country (2021-2026) & (US$ Million) Table 189. SAMEA Recombinant Protein Production Service Revenue by Country (US$ Million) & (2027-2032) Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Recombinant Protein Production Service Image Figure 2. Global Recombinant Protein Production Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Protein Production Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Mammalian Cell Based Image Figure 5. Bacteria Based Image Figure 6. Insect Cell Based Image Figure 7. Others Image Figure 8. Global Recombinant Protein Production Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Recombinant Protein Production Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Biomedicine Image Figure 11. Industrial Biotechnology Image Figure 12. Therapeutics Image Figure 13. Others Image Figure 14. Global Recombinant Protein Production Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Recombinant Protein Production Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Recombinant Protein Production Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Recombinant Protein Production Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Recombinant Protein Production Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Recombinant Protein Production Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Recombinant Protein Production Service Revenue Market Share by Type (2021-2032) Figure 22. Global Recombinant Protein Production Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Recombinant Protein Production Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Recombinant Protein Production Service Revenue Market Share by Application (2021-2032) Figure 25. North America Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 27. North America Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 28. North America Recombinant Protein Production Service Revenue Share by Country (2021-2032) Figure 29. United States Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 34. Europe Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 35. Europe Recombinant Protein Production Service Revenue Share by Country (2021-2032) Figure 36. Germany Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 46. China Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 47. Asia Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 49. Asia Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 50. Asia Recombinant Protein Production Service Revenue Share by Region (2021-2032) Figure 51. Japan Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Recombinant Protein Production Service Revenue Share by Country (2021-2032) Figure 61. Brazil Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Mammalian Cell Based
  • Bacteria Based
  • Insect Cell Based
  • Others
Applications
  • Biomedicine
  • Industrial Biotechnology
  • Therapeutics
  • Others
Companies covered
  • Charles River
  • Biomatik
  • R&D Systems
  • Applied Biological Materials Inc. (abm)
  • VectorBuilder
  • BiologicsCorp
  • Proteos
  • RayBiotech
  • Leinco Technologies
  • Kinexus Bioinformatics
  • InVivo BioTech Services GmbH
  • Expression Systems
  • Creative Biolabs
  • G &P Biosciences
  • Eurofins Discovery
  • Levprot Bioscience
  • eEnzyme
  • NorthX Biologics
  • Jubilant Biosys
  • GenScript
  • Boster Bio
  • Sino Biological
  • WuXi Biologic
  • CUSABIO TECHNOLOGY

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Protein Production Service Market by Type
  3. 1.2.1 Global Recombinant Protein Production Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Mammalian Cell Based
  5. 1.2.3 Bacteria Based
  6. 1.2.4 Insect Cell Based
  7. 1.2.5 Others
  8. 1.3 Recombinant Protein Production Service Market by Application
  9. 1.3.1 Global Recombinant Protein Production Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biomedicine
  11. 1.3.3 Industrial Biotechnology
  12. 1.3.4 Therapeutics
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Recombinant Protein Production Service Market Dynamics
  1. 2.1 Recombinant Protein Production Service Industry Trends
  2. 2.2 Recombinant Protein Production Service Industry Drivers
  3. 2.3 Recombinant Protein Production Service Industry Opportunities and Challenges
  4. 2.4 Recombinant Protein Production Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Recombinant Protein Production Service Market Perspective (2021-2032)
  2. 3.2 Global Recombinant Protein Production Service Growth Trends by Region
  3. 3.2.1 Global Recombinant Protein Production Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Protein Production Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Recombinant Protein Production Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Recombinant Protein Production Service Revenue by Players
  2. 4.1.1 Global Recombinant Protein Production Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Recombinant Protein Production Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Recombinant Protein Production Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Protein Production Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Recombinant Protein Production Service Key Players Headquarters & Area Served
  7. 4.4 Global Recombinant Protein Production Service Players, Product Type & Application
  8. 4.5 Global Recombinant Protein Production Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Recombinant Protein Production Service Market CR5 and HHI
  11. 4.6.3 2025 Recombinant Protein Production Service Tier 1, Tier 2, and Tier 3
5 Recombinant Protein Production Service Market Size by Type
  1. 5.1 Global Recombinant Protein Production Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 5.3 Global Recombinant Protein Production Service Revenue Market Share by Type (2021-2032)
6 Recombinant Protein Production Service Market Size by Application
  1. 6.1 Global Recombinant Protein Production Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Recombinant Protein Production Service Revenue by Application (2021-2032)
  3. 6.3 Global Recombinant Protein Production Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Charles River
  2. 7.1.1 Charles River Company Information
  3. 7.1.2 Charles River Business Overview
  4. 7.1.3 Charles River Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Charles River Recombinant Protein Production Service Product Portfolio
  6. 7.1.5 Charles River Recent Developments
  7. 7.2 Biomatik
  8. 7.2.1 Biomatik Company Information
  9. 7.2.2 Biomatik Business Overview
  10. 7.2.3 Biomatik Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biomatik Recombinant Protein Production Service Product Portfolio
  12. 7.2.5 Biomatik Recent Developments
  13. 7.3 R&D Systems
  14. 7.3.1 R&D Systems Company Information
  15. 7.3.2 R&D Systems Business Overview
  16. 7.3.3 R&D Systems Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 R&D Systems Recombinant Protein Production Service Product Portfolio
  18. 7.3.5 R&D Systems Recent Developments
  19. 7.4 Applied Biological Materials Inc. (abm)
  20. 7.4.1 Applied Biological Materials Inc. (abm) Company Information
  21. 7.4.2 Applied Biological Materials Inc. (abm) Business Overview
  22. 7.4.3 Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Product Portfolio
  24. 7.4.5 Applied Biological Materials Inc. (abm) Recent Developments
  25. 7.5 VectorBuilder
  26. 7.5.1 VectorBuilder Company Information
  27. 7.5.2 VectorBuilder Business Overview
  28. 7.5.3 VectorBuilder Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 VectorBuilder Recombinant Protein Production Service Product Portfolio
  30. 7.5.5 VectorBuilder Recent Developments
  31. 7.6 BiologicsCorp
  32. 7.6.1 BiologicsCorp Company Information
  33. 7.6.2 BiologicsCorp Business Overview
  34. 7.6.3 BiologicsCorp Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BiologicsCorp Recombinant Protein Production Service Product Portfolio
  36. 7.6.5 BiologicsCorp Recent Developments
  37. 7.7 Proteos
  38. 7.7.1 Proteos Company Information
  39. 7.7.2 Proteos Business Overview
  40. 7.7.3 Proteos Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Proteos Recombinant Protein Production Service Product Portfolio
  42. 7.7.5 Proteos Recent Developments
  43. 7.8 RayBiotech
  44. 7.8.1 RayBiotech Company Information
  45. 7.8.2 RayBiotech Business Overview
  46. 7.8.3 RayBiotech Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 RayBiotech Recombinant Protein Production Service Product Portfolio
  48. 7.8.5 RayBiotech Recent Developments
  49. 7.9 Leinco Technologies
  50. 7.9.1 Leinco Technologies Company Information
  51. 7.9.2 Leinco Technologies Business Overview
  52. 7.9.3 Leinco Technologies Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Leinco Technologies Recombinant Protein Production Service Product Portfolio
  54. 7.9.5 Leinco Technologies Recent Developments
  55. 7.10 Kinexus Bioinformatics
  56. 7.10.1 Kinexus Bioinformatics Company Information
  57. 7.10.2 Kinexus Bioinformatics Business Overview
  58. 7.10.3 Kinexus Bioinformatics Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Kinexus Bioinformatics Recombinant Protein Production Service Product Portfolio
  60. 7.10.5 Kinexus Bioinformatics Recent Developments
  61. 7.11 InVivo BioTech Services GmbH
  62. 7.11.1 InVivo BioTech Services GmbH Company Information
  63. 7.11.2 InVivo BioTech Services GmbH Business Overview
  64. 7.11.3 InVivo BioTech Services GmbH Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 InVivo BioTech Services GmbH Recombinant Protein Production Service Product Portfolio
  66. 7.11.5 InVivo BioTech Services GmbH Recent Developments
  67. 7.12 Expression Systems
  68. 7.12.1 Expression Systems Company Information
  69. 7.12.2 Expression Systems Business Overview
  70. 7.12.3 Expression Systems Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Expression Systems Recombinant Protein Production Service Product Portfolio
  72. 7.12.5 Expression Systems Recent Developments
  73. 7.13 Creative Biolabs
  74. 7.13.1 Creative Biolabs Company Information
  75. 7.13.2 Creative Biolabs Business Overview
  76. 7.13.3 Creative Biolabs Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Creative Biolabs Recombinant Protein Production Service Product Portfolio
  78. 7.13.5 Creative Biolabs Recent Developments
  79. 7.14 G &P Biosciences
  80. 7.14.1 G &P Biosciences Company Information
  81. 7.14.2 G &P Biosciences Business Overview
  82. 7.14.3 G &P Biosciences Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 G &P Biosciences Recombinant Protein Production Service Product Portfolio
  84. 7.14.5 G &P Biosciences Recent Developments
  85. 7.15 Eurofins Discovery
  86. 7.15.1 Eurofins Discovery Company Information
  87. 7.15.2 Eurofins Discovery Business Overview
  88. 7.15.3 Eurofins Discovery Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Eurofins Discovery Recombinant Protein Production Service Product Portfolio
  90. 7.15.5 Eurofins Discovery Recent Developments
  91. 7.16 Levprot Bioscience
  92. 7.16.1 Levprot Bioscience Company Information
  93. 7.16.2 Levprot Bioscience Business Overview
  94. 7.16.3 Levprot Bioscience Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Levprot Bioscience Recombinant Protein Production Service Product Portfolio
  96. 7.16.5 Levprot Bioscience Recent Developments
  97. 7.17 eEnzyme
  98. 7.17.1 eEnzyme Company Information
  99. 7.17.2 eEnzyme Business Overview
  100. 7.17.3 eEnzyme Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 eEnzyme Recombinant Protein Production Service Product Portfolio
  102. 7.17.5 eEnzyme Recent Developments
  103. 7.18 NorthX Biologics
  104. 7.18.1 NorthX Biologics Company Information
  105. 7.18.2 NorthX Biologics Business Overview
  106. 7.18.3 NorthX Biologics Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 NorthX Biologics Recombinant Protein Production Service Product Portfolio
  108. 7.18.5 NorthX Biologics Recent Developments
  109. 7.19 Jubilant Biosys
  110. 7.19.1 Jubilant Biosys Company Information
  111. 7.19.2 Jubilant Biosys Business Overview
  112. 7.19.3 Jubilant Biosys Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Jubilant Biosys Recombinant Protein Production Service Product Portfolio
  114. 7.19.5 Jubilant Biosys Recent Developments
  115. 7.20 GenScript
  116. 7.20.1 GenScript Company Information
  117. 7.20.2 GenScript Business Overview
  118. 7.20.3 GenScript Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 GenScript Recombinant Protein Production Service Product Portfolio
  120. 7.20.5 GenScript Recent Developments
  121. 7.21 Boster Bio
  122. 7.21.1 Boster Bio Company Information
  123. 7.21.2 Boster Bio Business Overview
  124. 7.21.3 Boster Bio Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Boster Bio Recombinant Protein Production Service Product Portfolio
  126. 7.21.5 Boster Bio Recent Developments
  127. 7.22 Sino Biological
  128. 7.22.1 Sino Biological Company Information
  129. 7.22.2 Sino Biological Business Overview
  130. 7.22.3 Sino Biological Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Sino Biological Recombinant Protein Production Service Product Portfolio
  132. 7.22.5 Sino Biological Recent Developments
  133. 7.23 WuXi Biologic
  134. 7.23.1 WuXi Biologic Company Information
  135. 7.23.2 WuXi Biologic Business Overview
  136. 7.23.3 WuXi Biologic Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 WuXi Biologic Recombinant Protein Production Service Product Portfolio
  138. 7.23.5 WuXi Biologic Recent Developments
  139. 7.24 CUSABIO TECHNOLOGY
  140. 7.24.1 CUSABIO TECHNOLOGY Company Information
  141. 7.24.2 CUSABIO TECHNOLOGY Business Overview
  142. 7.24.3 CUSABIO TECHNOLOGY Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 CUSABIO TECHNOLOGY Recombinant Protein Production Service Product Portfolio
  144. 7.24.5 CUSABIO TECHNOLOGY Recent Developments
8 North America
  1. 8.1 North America Recombinant Protein Production Service Revenue (2021-2032)
  2. 8.2 North America Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 8.3 North America Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 8.5 North America Recombinant Protein Production Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Recombinant Protein Production Service Revenue by Country
  11. 8.6.1 North America Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Recombinant Protein Production Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Recombinant Protein Production Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Protein Production Service Revenue (2021-2032)
  2. 9.2 Europe Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 9.3 Europe Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 9.5 Europe Recombinant Protein Production Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Recombinant Protein Production Service Revenue by Country
  11. 9.6.1 Europe Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Recombinant Protein Production Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Recombinant Protein Production Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Recombinant Protein Production Service Revenue (2021-2032)
  2. 10.2 China Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 10.2.1 China Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 10.2.2 China Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 10.3 China Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 10.4 China Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 10.4.1 China Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 10.4.2 China Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 10.5 China Recombinant Protein Production Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Protein Production Service Revenue (2021-2032)
  2. 11.2 Asia Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 11.3 Asia Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 11.5 Asia Recombinant Protein Production Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Recombinant Protein Production Service Revenue by Country
  11. 11.6.1 Asia Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Recombinant Protein Production Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Recombinant Protein Production Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Protein Production Service Revenue (2021-2032)
  2. 12.2 SAMEA Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Recombinant Protein Production Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Recombinant Protein Production Service Revenue by Country
  11. 12.6.1 SAMEA Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Recombinant Protein Production Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Recombinant Protein Production Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst